GlassScriptPhysician profile
Mohammad Beizaeipour
NPI 1346774429
$7,574.48
in general payments reported to CMS, 2019-2025
19 companies · $881 in 2025
The $881 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $325 · 2022: $1,083 · 2023: $3,902 · 2024: $1,383 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,444 · Grant: $2,000 · Travel and Lodging: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,444.13 |
| Grant | $2,000.00 |
| Travel and Lodging | $722.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,680.47 | 2022-2024 | Corevalve Evolut R |
| Boston Scientific Corporation | $2,537.18 | 2022-2025 | Avvigo Guidance System, General - Therapies, Rotablator Rotational Atherectomy System Console Kit |
| Biotronik INC. | $713.18 | 2021-2024 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Philips North America LLC | $198.44 | 2021-2023 | |
| Aop Health US, LLC | $195.65 | 2025 | Rapiblyk |
| Atricure, INC. | $188.17 | 2022 | |
| Cvrx, INC. | $181.09 | 2025 | Barostim Neo System |
| Saranas, INC. | $142.59 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $127.25 | 2022 | |
| Edwards Lifesciences Corporation | $125.62 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inari Medical, INC. | $115.57 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $106.12 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $85.07 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.01 | 2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $41.14 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $30.50 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $20.79 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $18.82 | 2025 | Camzyos |
| Scpharmaceuticals INC. | $17.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Beizaeipour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.